Decheng Capital as of June 30, 2025
Portfolio Holdings for Decheng Capital
Decheng Capital holds 25 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cg Oncology (CGON) | 41.8 | $166M | 6.4M | 26.00 | |
| Aardvark Therapeutics (AARD) | 13.4 | $53M | 3.9M | 13.52 | |
| Nuvation Bio (NUVB) | 12.8 | $51M | 26M | 1.95 | |
| Upstream Bio (UPB) | 9.1 | $36M | 3.3M | 10.98 | |
| Newamsterdam Pharma Co Nv (NAMS) | 3.5 | $14M | 770k | 18.11 | |
| BeyondSpring SHS (BYSI) | 2.7 | $11M | 4.5M | 2.35 | |
| Merus N V (MRUS) | 2.5 | $9.9M | 189k | 52.60 | |
| Krystal Biotech (KRYS) | 2.3 | $9.1M | 66k | 137.46 | |
| Helix Acquisition Corp | 2.2 | $8.6M | 182k | 47.20 | |
| Revolution Medicines (RVMD) | 2.1 | $8.3M | 226k | 36.79 | |
| Aclaris Therapeutics (ACRS) | 1.4 | $5.7M | 4.0M | 1.42 | |
| Lyell Immunopharma | 1.3 | $5.3M | 596k | 8.84 | |
| Arcellx (ACLX) | 1.1 | $4.5M | 548k | 8.14 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.0 | $4.1M | 143k | 28.76 | |
| Aura Biosciences (AURA) | 0.8 | $3.2M | 516k | 6.26 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.4 | $1.5M | 1.3M | 1.16 | |
| Equillium (EQ) | 0.4 | $1.4M | 4.4M | 0.32 | |
| 4d Molecular Therapeutics In (FDMT) | 0.2 | $889k | 240k | 3.71 | |
| Arcus Biosciences Incorporated (RCUS) | 0.2 | $811k | 160k | 5.07 | |
| Illumina (ILMN) | 0.2 | $761k | 8.0k | 95.41 | |
| Legend Biotech Corp- Adr (LEGN) | 0.2 | $710k | 20k | 35.49 | |
| Grail (GRAL) | 0.1 | $498k | 9.7k | 51.42 | |
| Pyxis Oncology (PYXS) | 0.1 | $360k | 327k | 1.10 | |
| Rezolute (RZLT) | 0.1 | $267k | 60k | 4.46 | |
| Nuvation Bio Warrants (NUVB.WS) | 0.0 | $127k | 646k | 0.20 |
